Maintenance Therapy for Multiple Myeloma with Particular Emphasis on Thalidomide

Publisher： Karger

E-ISSN： 2296-5262|29|12|582-590

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.29, Iss.12, 2006-12, pp. : 582-590

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacoeconomic Implications of Lenalidomide Maintenance Therapy in Multiple Myeloma

By  

Oncology, Vol. 87, Iss. 4, 2014-07 ,pp. : 224-231

Karger

Access to resources Recommend Favorite

Bortezomib with Thalidomide plus Dexamethasone Compared with Thalidomide plus Doxorubicin and Dexamethasone as Induction Therapy in Previously Untreated Multiple Myeloma Patients

By  

Acta Haematologica, Vol. 129, Iss. 1, 2012-10 ,pp. : 35-39

Karger

Access to resources Recommend Favorite

The Future Role of Thalidomide in Multiple Myeloma

By  

Acta Haematologica, Vol. 114, Iss. 1, 2005-09 ,pp. : 18-22

Karger

Access to resources Recommend Favorite

Bortezomib‐thalidomide‐dexamethasone versus bortezomib‐cyclophosphamide‐dexamethasone as induction therapy prior to autologous stem cell transplantation in multiple myeloma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 4, 2015-02 ,pp. : 605-606

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Current Status of Thalidomide in the Management of Multiple Myeloma

By  

Acta Haematologica, Vol. 114, Iss. 1, 2005-09 ,pp. : 3-7

Karger

Access to resources Recommend Favorite